• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏和雌激素替代研究(HERS)及妇女健康倡议(WHI)之后女性对激素疗法的态度及使用情况的变化

Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.

作者信息

Hoffmann Mikael, Hammar Mats, Kjellgren Karin I, Lindh-Astrand Lotta, Brynhildsen Jan

机构信息

Division of Clinical Pharmacology, Department of Medicine and Care, Linköping University, SE-581 83 Linköping, Sweden.

出版信息

Maturitas. 2005 Sep 16;52(1):11-7. doi: 10.1016/j.maturitas.2005.06.003.

DOI:10.1016/j.maturitas.2005.06.003
PMID:16023804
Abstract

OBJECTIVES

To assess changes in women's attitudes towards risk and benefits of, and use of hormone treatment in the menopausal transition (HT) before and after Heart and Estrogen/Progestin Replacement Study (HERS) and the oestrogen and progestin trial of Women's Health Initiative (WHI).

METHODS

Postal questionnaires to all women 53 and 54 years of age in a Swedish community in 1999 (n=1.760) and 2003 (n=1.733). Data on sales of HT were collected from the database of the National Corporation of Swedish Pharmacies.

RESULTS

The fraction of women reporting current use of HT fell from 40.5 to 25.3% (p<0.001, chi2-test) both by fewer women starting and more women discontinuing treatment. This corresponded to a decrease in dispensation of HT in Linköping and nationwide for the same age group. The fraction of women who had tried complementary treatment for climacteric discomfort, increased from 9.6 to 18.1% for natural remedies (p<0.001, chi2-test). Women perceived HT as more risky and less beneficial in 2003 as compared with 1999 (both p<0.001, chi2-test). The most frequent source of information about HT during the last year before the 2003 questionnaire were newspaper or magazines (43.8%) and television or radio (31.7%).

CONCLUSIONS

The decreased use of HT in the community correlated with pronounced changes in the attitudes towards HT. Media were a more frequent source of information than health care personnel. This indicates that media reports about major clinical studies might have influenced the use of HT among women.

摘要

目的

评估在心脏和雌激素/孕激素替代研究(HERS)以及妇女健康倡议(WHI)的雌激素和孕激素试验前后,处于绝经过渡期的女性对激素治疗(HT)的风险、益处及使用情况的态度变化。

方法

于1999年(n = 1760)和2003年(n = 1733)向瑞典一个社区中所有53和54岁的女性邮寄调查问卷。从瑞典国家药房公司的数据库收集HT的销售数据。

结果

报告当前正在使用HT的女性比例从40.5%降至25.3%(p<0.001,卡方检验),原因是开始治疗的女性减少且停止治疗的女性增多。这与林雪平及全国同年龄组HT配药量的减少相对应。尝试过针对更年期不适进行补充治疗的女性比例,天然疗法从9.6%增至18.1%(p<0.001,卡方检验)。与1999年相比,2003年女性认为HT风险更高且益处更少(均为p<0.001,卡方检验)。在2003年问卷调查前的最后一年,关于HT的最常见信息来源是报纸或杂志(43.8%)以及电视或广播(31.7%)。

结论

社区中HT使用的减少与对HT态度的显著变化相关。媒体是比医护人员更常见的信息来源。这表明关于重大临床研究的媒体报道可能影响了女性对HT的使用。

相似文献

1
Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.心脏和雌激素替代研究(HERS)及妇女健康倡议(WHI)之后女性对激素疗法的态度及使用情况的变化
Maturitas. 2005 Sep 16;52(1):11-7. doi: 10.1016/j.maturitas.2005.06.003.
2
Attitudes towards the menopause and hormone therapy over the turn of the century.世纪之交对更年期及激素疗法的态度。
Maturitas. 2007 Jan 20;56(1):12-20. doi: 10.1016/j.maturitas.2006.05.002. Epub 2006 Jun 23.
3
Patients' and clinicians' attitudes after the Women's Health Initiative study.女性健康倡议研究后患者与临床医生的态度
Menopause. 2004 Jan-Feb;11(1):57-61. doi: 10.1097/01.GME.0000075503.60230.61.
4
After the Women's Health Initiative: decision making and trust of women taking hormone therapy.女性健康倡议之后:接受激素治疗女性的决策与信任
Womens Health Issues. 2005 Jul-Aug;15(4):187-95. doi: 10.1016/j.whi.2005.03.003.
5
Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.妇女健康倡议试验公布前后激素治疗的使用趋势:10年随访
Menopause. 2009 Sep-Oct;16(5):1061-4. doi: 10.1097/gme.0b013e3181a02b44.
6
The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
Menopause. 2005 Jul-Aug;12(4):405-11. doi: 10.1097/01.GME.0000153890.77135.00. Epub 2005 Jul 21.
7
Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.“女性健康倡议”研究后韩国临床医生对绝经后激素治疗的态度
Menopause. 2006 Jan-Feb;13(1):125-9. doi: 10.1097/01.gme.0000191211.51232.9d.
8
Women's trust in and use of information sources in the treatment of menopausal symptoms.女性在更年期症状治疗中对信息来源的信任及使用情况。
Womens Health Issues. 2009 Mar-Apr;19(2):144-53. doi: 10.1016/j.whi.2009.01.004.
9
Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.在内科诊所就诊的女性中,女性健康倡议之后的更年期症状管理与预防咨询。
J Womens Health (Larchmt). 2005 Jul-Aug;14(6):507-14. doi: 10.1089/jwh.2005.14.507.
10
Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.妇女健康倡议前后女性对激素疗法的使用:稳定性与变化的社会心理模型
Prev Med. 2006 Sep;43(3):158-64. doi: 10.1016/j.ypmed.2006.04.008. Epub 2006 Jun 5.

引用本文的文献

1
Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case-control study in Sweden.绝经激素治疗与类肉瘤病风险:瑞典基于人群的巢式病例对照研究。
Eur J Epidemiol. 2024 Mar;39(3):313-322. doi: 10.1007/s10654-023-01084-3. Epub 2024 Jan 12.
2
Facing Provider Misconceptions Towards the Use of Hormone Therapy in 2020.2020年应对医疗服务提供者对激素疗法使用的误解
J Gen Intern Med. 2021 Mar;36(3):767-768. doi: 10.1007/s11606-020-05940-w. Epub 2020 Jun 4.
3
Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.
在HER2阳性乳腺癌小鼠模型中,将褪黑素与雌二醇 - 孕酮更年期激素疗法联合使用可抑制乳腺癌发展。
Front Oncol. 2019 Jul 9;9:525. doi: 10.3389/fonc.2019.00525. eCollection 2019.
4
Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries.五个欧洲国家中影响更年期症状治疗决策的行为和态度。
Post Reprod Health. 2016 Sep;22(3):112-22. doi: 10.1177/2053369116632439. Epub 2016 Feb 18.
5
Knowledge of reproductive physiology and hormone therapy in 40-60 year old women: a population-based study in Yazd, Iran.40至60岁女性生殖生理学与激素治疗知识:伊朗亚兹德的一项基于人群的研究
Iran J Reprod Med. 2012 Jul;10(4):383-90.
6
Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study.金雀异黄素对骨质疏松绝经后女性生活质量和抑郁症状的影响:一项为期2年的随机、双盲、对照研究。
Osteoporos Int. 2014 Mar;25(3):1123-9. doi: 10.1007/s00198-013-2512-5. Epub 2013 Oct 10.
7
Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis.绝经后妇女对激素治疗 (HT) 的知识、认知和信息:系统评价和综合分析。
PLoS One. 2011;6(9):e24661. doi: 10.1371/journal.pone.0024661. Epub 2011 Sep 16.
8
Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.组织选择性雌激素复合物:绝经症状综合管理的有前途选择。
Drugs Aging. 2010 Jul 1;27(7):533-44. doi: 10.2165/11316000-000000000-00000.
9
Variability in short-wavelength automated perimetry among peri- or postmenopausal women: a dependence on phyto-oestrogen consumption?绝经前后女性短波长自动视野计检查的变异性:是否与植物雌激素的摄入有关?
Acta Ophthalmol. 2011 May;89(3):e217-24. doi: 10.1111/j.1755-3768.2009.01799.x.
10
Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.1998年至2003年间德国女性更年期激素疗法使用情况的差异。
BMC Womens Health. 2007 Oct 18;7:19. doi: 10.1186/1472-6874-7-19.